Photo from wikipedia
Since July 2021, a worldwide shortage of verteporfin (Visudyne®) occurred: an essential medicine required for photodynamic therapy (PDT). PDT with verteporfin has a broad range of indications in ophthalmology, including… Click to show full abstract
Since July 2021, a worldwide shortage of verteporfin (Visudyne®) occurred: an essential medicine required for photodynamic therapy (PDT). PDT with verteporfin has a broad range of indications in ophthalmology, including chronic central serous chorioretinopathy, polypoidal choroidal vasculopathy and choroidal haemangioma. For these disorders, PDT is either the first‐choice treatment or regarded as a major treatment option.
Keywords:
verteporfin visudyne;
shortage verteporfin;
verteporfin;
worldwide shortage
Journal Title: Acta Ophthalmologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Ophthalmologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!